Sanofi Pasteur's Investigational H5N1 Influenza Vaccine Achieves High Immune Response at ...(n Reform Act of 1995 as amended.Forward-...)

Date:9/17/2007

n Reform Act of 1995, as amended. Forward-looking statements are statements that are not historical facts. These statements include financial projections and estimates and their underlying assumptions, statements regarding plans, objectives, intentions and expectations with respect to future events, operations, products and services, and statements regarding future performance. Forward-looking statements are generally identified by the words "expects," "anticipates," "believes," "intends," "estimates," "plans" and similar expressions. Although sanofi-aventis' management believes that the expectations reflected in such forward-looking statements are reasonable, investors are cautioned that forward-looking information and statements are subject to various risks and uncertainties, many of which are difficult to predict and generally beyond the control of sanofi-aventis, that could cause actual results and developments to differ materially from those expressed in, or implied or projected by, the forward-looking information and statements. These risks and uncertainties include those discussed or identified in the public filings with the SEC and the AMF made by sanofi-aventis, including those listed under "Risk Factors" and "Cautionary Statement Regarding Forward-Looking Statements" in sanofi-aventis' annual report on Form 20-F for the year ended December 31, 2006. Other than as required by applicable law, sanofi-aventis does not undertake any obligation to update or revise any forward-looking information or statements.

Reference (1): http://www.who.int/vaccine_research/diseases/ari/en/print.html

Sanofi Pasteur

Pascal Barollier

International Media Relations

Tel: +33-(0)4-37-37-51-41

pascal.barollier@sanofipasteur.com

Len Lavenda

U.S. Media Relations

Tel: +1-570-839-4446'/>"/>

SOURCE Sanofi Pasteur Copyright©2007 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5
Related biology technology :

1. New Mexico firm to make flu vaccine at Wisconsin BioManufacturing facility
2. Studies Offer New Insight into HIV Vaccine Development
3. Inacom Information Systems achieves Cisco Systems Partner -Gold Certified status
4. Third Wave Achieves Milestone, Delivers 200,000 SNP Assays to RIKEN In Japan
5. Immune boosting beverage relying on Milwaukee firms packaging technology
6. UW scientist wins Pew grant to study little-known immune cells
7. Performance of Ad-A-Gene Cyclic AMP Response Element-Nitroreductase (CRE-NTR): an adenoviral vector gene delivery system
8. FLIPR Calcium 3 Assay Kit - An Optimal No-Wash Fluorescence Calcium Indicator Reagent for Non-Optimal Calcium Responses
9. IT critical in pandemic response, but many are not paying attention
10. Quick response manufacturing and biotech